BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 28586952)

  • 1. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
    Press RH; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Burri SH; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Crocker IR; Prabhu RS
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):632-638. PubMed ID: 28581405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery.
    McTyre ER; Soike MH; Farris M; Ayala-Peacock DN; Hepel JT; Page BR; Shen C; Kleinberg L; Contessa JN; Corso C; Chiang V; Henson-Masters A; Cramer CK; Ruiz J; Pasche B; Watabe K; D'Agostino R; Su J; Laxton AW; Tatter SB; Fiveash JB; Ahluwalia M; Kotecha R; Chao ST; Braunstein SE; Attia A; Chung C; Chan MD
    Radiother Oncol; 2020 Jan; 142():168-174. PubMed ID: 31526671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery.
    LeCompte MC; Hughes RT; Farris M; Masters A; Soike MH; Lanier C; Glenn C; Cramer CK; Watabe K; Su J; Ruiz J; Whitlow CT; Wang G; Laxton AW; Tatter SB; Chan MD
    J Neurooncol; 2020 Jan; 146(2):285-292. PubMed ID: 31894518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
    Press RH; Prabhu RS; Nickleach DC; Liu Y; Shu HK; Kandula S; Patel KR; Curran WJ; Crocker I
    Cancer; 2015 Nov; 121(21):3836-43. PubMed ID: 26242475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.
    McTyre E; Ayala-Peacock D; Contessa J; Corso C; Chiang V; Chung C; Fiveash J; Ahluwalia M; Kotecha R; Chao S; Attia A; Henson A; Hepel J; Braunstein S; Chan M
    Ann Oncol; 2018 Feb; 29(2):497-503. PubMed ID: 29161348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
    Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
    Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.
    Likhacheva A; Pinnix CC; Parikh NR; Allen PK; McAleer MF; Chiu MS; Sulman EP; Mahajan A; Guha-Thakurta N; Prabhu SS; Cahill DP; Luo D; Shiu AS; Brown PD; Chang EL
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):656-61. PubMed ID: 22898384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
    Gorovets D; Ayala-Peacock D; Tybor DJ; Rava P; Ebner D; Cielo D; Norén G; Wazer DE; Chan M; Hepel JT
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):246-253. PubMed ID: 28068233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
    Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma.
    Goyal LK; Suh JH; Reddy CA; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1007-12. PubMed ID: 10863072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases.
    Hodgson DC; Charpentier AM; Cigsar C; Atenafu EG; Ng A; Bahl G; Zadeh G; San Miguel J; Menard C
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):335-40. PubMed ID: 22704984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
    Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
    Hughes RT; Masters AH; McTyre ER; Farris MK; Chung C; Page BR; Kleinberg LR; Hepel J; Contessa JN; Chiang V; Ruiz J; Watabe K; Su J; Fiveash JB; Braunstein S; Chao S; Attia A; Ayala-Peacock DN; Chan MD
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1091-1098. PubMed ID: 30959122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy.
    McTyre ER; Johnson AG; Ruiz J; Isom S; Lucas JT; Hinson WH; Watabe K; Laxton AW; Tatter SB; Chan MD
    Neuro Oncol; 2017 Apr; 19(4):558-566. PubMed ID: 27571883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.